Skip to main navigation

Investor Relations

Home
Investors & Media
Contact Us
Careers

Overview
News / Events
Financial
- Annual Reports & Proxies
- Financial Results
Stock
SEC Filings
- All SEC Filings
Corporate Governance

Overview
News / Events
Financial
- Annual Reports & Proxies
- Financial Results
Stock
SEC Filings
- All SEC Filings
Corporate Governance

Press Coverage

Year

Jan 11, 2023

BioXcel, keeping cards close to its chest, teases phase 2 Keytruda combination trial data drop

Jan 11, 2023

BioXcel Spinout Posts Promising Results in Rare Prostate Cancer

Jan 06, 2023

Genetics, Alzheimer's And AI — Why 2023 Could Be The Year For Biotech Stocks

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 13 of 13

Site - Investor Tools

Print Page

Tear Sheet

Email Alerts

RSS Feeds

Contacts

Search

About Us
Our Products
Our Pipeline
Our Science
Patients & Advocacy

Home
Investors & Media
Contact Us
Careers

Copyright © 2023 BioXcel Therapeutics, Inc. All Rights Reserved.

Privacy Policy
Disclaimer
Sitemap